Pharmacology and the nursing process / (Record no. 6712)

MARC details
000 -LEADER
fixed length control field 03690cam a2200289 a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20231012125129.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120324s2005 moua b 001 0 eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780323012676
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0323012671
040 ## - CATALOGING SOURCE
Original cataloging agency BUL
Transcribing agency BUL
Modifying agency BUL
Language of cataloging eng
Description conventions rda
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number QV 4 L729p 2001
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Lilley, Linda Lane.
245 10 - TITLE STATEMENT
Title Pharmacology and the nursing process /
Statement of responsibility, etc. Linda Lane Lilley, Robert S. Aucker ; with study skills content by Richard E. Lake.
250 ## - EDITION STATEMENT
Edition statement 3rd edition.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. St. Louis, Mo. :
Name of publisher, distributor, etc. Mosby/Elsevier,
Date of publication, distribution, etc. c2005.
300 ## - PHYSICAL DESCRIPTION
Extent xx, 922 p. :
Other physical details col. ill. ;
Dimensions 29 cm. +
Accompanying material 1 CD-ROM (4 3/4 in.)
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Contents<br/>Part One. PHARMACOLOGY BASICS · <br/>1. The Nursing Process and Drug Therapy ·<br/>2. Pharmacologic Principles · <br/>3. Life Span Considerations · <br/>4. Legal, Ethical, and Cultural Considerations · <br/>5. Patient Education and Drug Therapy · <br/>6. Herbal Remedies and Over-the-Counter Drugs · <br/>7. Substance Abuse · <br/>8. Photo Atlas of Drug Administration · <br/><br/><br/>Part Two. DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM ·<br/>9. Drug Therapy for Treatment of Pain, Fever and Inflammation <br/>10. General and Local Anesthetic Agents · <br/>11. Central Nervous System Depressants · <br/>12. Antiepileptic Agents · <br/>13. Antiparkinsonian Agents · <br/>14. Psychotherapeutic Agents · <br/>15. Central Nervous System Stimulant Agents · <br/><br/>Part Three. DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM · <br/>16. Adregenic Agents · <br/>17. Adregenic-Blocking Agents · <br/>18. Cholinergic Agents · <br/>19. Cholinergenic-Blocking Agents · <br/><br/>Part Four. DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS ·<br/>20. Positive Inotropic Agents · <br/>21. Antidysrhythmic Agents · <br/>22. Antianginal Agents · <br/>23. Antihypertensive Agents · <br/>24. Diuretic Agents · <br/>25. Fluids and Electrolytes · <br/>26. Coagulation Modifier Agents · <br/>27. Antilipemic Agents · <br/><br/>Part Five. DRUGS AFFECTING THE ENDOCRINE SYSTEM · <br/>28. Pituitary Agents · <br/>29. Thyroid and Antithyroid Agents · <br/>30. Antidiabetic and Hypoglycemin Agents · <br/>31. Adrenal Agents · <br/>32. Women's Health Agents · <br/>33. Men's Health Agents · <br/><br/>Part Six. DRUGS AFFECTING THE RESPIRATORY SYSTEM · <br/>34. Antihistamines, Decongestants, Antitissives, and Expectorants · <br/>35. Bronchodilators and Other Respiratory Agents ·<br/>Part Seven. ANTIINFECTIVE AND ANTIINFLAMMATORY AGENTS· <br/>36. Antibiotics · <br/>37. Antiviral Agents · <br/>38. Antitubercular Agents · <br/>39. Antifungal Agents · <br/>40. Antimalarial, Antiprotozal, and Antihelmintic Agents · <br/>41. Antiseptic and Disinfectant Agents · <br/>42. Antiinflammatory Agents · <br/><br/>Part Eight. IMMUNE AND BIOLOGIC MODIFIERS AND CHEMOTHERAPEUTIC AGENTS · <br/>43. Immunosuppressant Agents ·<br/>44. Immunizing Agents · <br/>45. Antineoplastic Agents · <br/>46. Biologic Response Modifiers ·<br/><br/>Part Nine. DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM AND NUTRITION · <br/>47. Antacids and Antiflatulents · <br/>48. Antidiarrheals and Laxatives · <br/>49. Antiemetic (Antinausea) Agents · <br/>50. Vitamins and Minerals · <br/>51. Nutritional Supplements ·<br/> <br/>Part Ten. MISCELLANEOUS THERAPEUTICS: HEMATOLOGIC, DERMATOLOGIC, OPHTHALMIC, AND OTIC AGENTS · <br/>52. Blood-Forming Agents · <br/>53. Dermatologic Agents · <br/>54. Ophthalimic Agents · <br/>55. Otic Agents · <br/>
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nursing.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Aucker, Robert S.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lake, Richard E.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Book Open Access
Edition 3rd edition
Classification part QV 4 L729p 2001
Item part 1
Call number prefix QV 4
Call number suffix L729p 2001
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Source of acquisition Total Checkouts Full call number Barcode Date last seen Copy number Price effective from Koha item type Inventory number
    Dewey Decimal Classification     Engineering Library Engineering Library 10/07/2021 Donation   615.1 LIL 1 BUML22020751 10/07/2021 1 10/07/2021 Book Open Access  
    Dewey Decimal Classification     Engineering Library Engineering Library 10/11/2021 Donation   615.1 LIL 2 BUML22020750 10/11/2021 2 10/11/2021 Book Open Access  
    Dewey Decimal Classification     Health Sciences Library Health Sciences Library 02/15/2022 Donation   QV 4 L729p 2001 MBAL22020749 02/15/2022 3 02/15/2022 Book Open Access 01239